Evidence map›Paper›PMID 32998392›Full record

ArticleInternational journal of molecular sciences2020

Early Stimulation of TREK Channel Transcription and Activity Induced by Oxaliplatin-Dependent Cytosolic Acidification.

Marianna Dionisi, Federico Alessandro Ruffinatti, Beatrice Riva, Dmitry Lim, Annalisa Canta, Cristina Meregalli, Giulia Fumagalli, Laura Monza, Antonio Ferrer-Montiel, Asia Fernandez-Carvajal and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Marianna DionisiDepartment of Pharmaceutical Sciences, University of Piemonte Orientale, Via Bovio 6, 28100 Novara, Italy.
Federico Alessandro RuffinattiDepartment of Pharmaceutical Sciences, University of Piemonte Orientale, Via Bovio 6, 28100 Novara, Italy.ORCID 0000-0002-3084-0380
Beatrice RivaDepartment of Pharmaceutical Sciences, University of Piemonte Orientale, Via Bovio 6, 28100 Novara, Italy.
Dmitry LimDepartment of Pharmaceutical Sciences, University of Piemonte Orientale, Via Bovio 6, 28100 Novara, Italy.ORCID 0000-0002-4316-2654
Annalisa CantaExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, Italy.
Cristina MeregalliExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, Italy.ORCID 0000-0002-4281-4577
Giulia FumagalliExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, Italy.
Laura MonzaExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, Italy.
Antonio Ferrer-MontielBiología Molecular y Celular, Universidad Miguel Hernández de Elche, 03202 Elche (Alicante), Spain.
Asia Fernandez-CarvajalBiología Molecular y Celular, Universidad Miguel Hernández de Elche, 03202 Elche (Alicante), Spain.ORCID 0000-0003-2741-1427
Guido CavalettiExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, Italy.ORCID 0000-0003-4128-2406
Armando A GenazzaniDepartment of Pharmaceutical Sciences, University of Piemonte Orientale, Via Bovio 6, 28100 Novara, Italy.
Carla DistasiDepartment of Pharmaceutical Sciences, University of Piemonte Orientale, Via Bovio 6, 28100 Novara, Italy.ORCID 0000-0001-8815-3252
Università degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITUniversity of Milano-Bicocca · ITUniversitat de Miguel Hernández d'Elx · ES

Funding

AEI-MCII RTI2018-097189-B-C21AIRC IG 2016 Id.18631MIUR PRIN 2017ZFJCS3UMH PAR-2019
6 · The paper itself

Abstract

Oxaliplatin-induced peripheral neuropathy is characterized by an acute hyperexcitability syndrome triggered/exacerbated by cold. The mechanisms underlying oxaliplatin-induced peripheral neuropathy are unclear, but the alteration of ion channel expression and activity plays a well-recognized central role. Recently, we found that oxaliplatin leads to cytosolic acidification in dorsal root ganglion (DRG) neurons. Here, we investigated the early impact of oxaliplatin on the proton-sensitive TREK potassium channels. Following a 6-h oxaliplatin treatment, both channels underwent a transcription upregulation that returned to control levels after 42 h. The overexpression of TREK channels was also observed after in vivo treatment in DRG cells from mice exposed to acute treatment with oxaliplatin. Moreover, both intracellular pH and TREK channel transcription were similarly regulated after incubation with amiloride, an inhibitor of the Na

Indexed as

Action PotentialsAmilorideAnimalsAntineoplastic AgentsCapsaicinEpithelial Sodium Channel BlockersGanglia, SpinalHumansHydrogen-Ion ConcentrationMaleMiceMice, Inbred BALB CModels, BiologicalNeuronsOxaliplatinPatch-Clamp TechniquesAmilorideAntineoplastic AgentsCapsaicinEpithelial Sodium Channel BlockersOxaliplatinpotassium channel protein TREK-1Potassium Channels, Tandem Pore DomainSodium-Hydrogen Exchanger 1DRG neuronselectrophysiologyNa+/H+ exchangerneuropathic painoxaliplatinpHTREK channelsTRPV1

Identifiers

PMID32998392
PMCPMC7584002
OpenAlexW3088546871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.